InvestorsHub Logo
icon url

manibiotech

07/02/24 10:27 AM

#703254 RE: newman2021 #703244

Lol
When others said the same thing long time ago they were called fudsters . I.e. get approval in whatever fashion ASAP and then keep working on refinements .
icon url

ilovetech

07/02/24 10:37 AM

#703258 RE: newman2021 #703244

If the answer is dcvax, when asked, "what treatment would you seek if you were diagnosed with GBM?" Then know the market will come to NWBO. That's why I sold Amrn, because no matter how fantastic, adding 25% ARR of a Cardiac Event and or Stroke, which is on top of the 25% ARR, when taking a statin alone, Vascepa should fly off pharmacy shelves, but they're not. Sales are flat. Worse, patient compliance drops off by 50% after six months. That's why CVD is called the silent killer. There's not enough fear, pain, and disability, sadly, when addressing prevention. Astonishing, but true. You need to scare the bejesus out of people to change their behavior patterns apparently. 4 years after approval, and physician awareness is flat.
GBM is as scary, debilitating, and terminal as it gets. So one way or the other, all roads lead to Rome.
icon url

sukus

07/02/24 10:51 AM

#703265 RE: newman2021 #703244

If you are a BP I think you would do the same too :)

You ask LP preparing preparing preparing.

When preparation is done, you are ready with the money.

Reciprocal relationship, right Newman?